Learn More
Medchemexpress LLC PKC-theta inhibitor 1 | 1160501-81-4 | 99.7% | 348.32 g·mol⁻¹ | C17H15F3N4O | 1MG

Supplier: Medchemexpress LLC HY1263281MG
PKC-theta inhibitor 1 is an orally active, selective ATP-competitive inhibitor of protein kinase C theta (PKCθ) intended for preclinical research. It exhibits high binding potency (Ki = 6 nM), suppresses T-cell-mediated release of proinflammatory cytokines in cellular assays (IL-2 IC50 = 0.21 μM; IL-17 IC50 = 1 μM), and has molecular formula C17H15F3N4O with a molecular weight of 348.32 g·mol⁻¹. For research use only.
- Selective ATP-competitive inhibition of PKCθ with high binding potency.
- Demonstrated cellular activity against IL-2 and IL-17 production.
- Orally active compound with in vivo efficacy in autoimmune models.
- High chemical purity suitable for research applications.
- Available in small pack sizes for dose-ranging and pilot studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.